At a glance
- Originator Auxilium Pharmaceuticals
- Developer Endo International
- Class Amides; Benzene derivatives; General anaesthetics; Opioid analgesics; Piperidines; Small molecules
- Mechanism of Action Opioid mu receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes - Pain
Highest Development Phases
- No development reported Acute pain
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Acute pain in USA (Transmucosal, Film)
- 29 Jan 2015 Auxilium Pharmaceuticals has been acquired by Endo International
- 01 Feb 2011 Fentanyl transmucosal is available for licensing in World as of 01 Feb 2011. www.auxilium.com